Results 161 to 170 of about 423,879 (287)

The British Society For Rheumatology guideline for the management of gout [PDF]

open access: yes, 2017
Cameron, Stewart   +13 more
core   +6 more sources

Utility of the Morisky Medication Adherence Scale in gout: a prospective study

open access: yesPatient Preference and Adherence, 2016
CSL Tan,1 GG Teng,1,2 KJ Chong,2 PP Cheung,1,2 AYN Lim,1,2 HL Wee,3,4 A Santosa1,2 1University Medicine Cluster, Division of Rheumatology, National University Health System, 2Department of Medicine, Yong Loo Lin School of Medicine, 3Department of ...
Tan CSL   +6 more
doaj  

SAT0416 ULTRASOUND EVALUATION IN FOLLOW-UP OF URATE-LOWERING THERAPY IN GOUT PHASE 2 (USEFUL-2): DURATION OF FLARE PROPHYLAXIS [PDF]

open access: bronze, 2019
Esther Ebstein   +13 more
openalex   +1 more source

Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review [PDF]

open access: gold, 2021
Hamish Farquhar   +6 more
openalex   +1 more source

Роль оцінки якості життя та здоров’я з індексом життєдіяльності у пацієнтів з артеріальною гіпертензією в поєднанні з подагрою в практиці сімейного лікаря [PDF]

open access: yes, 2018
Количество исследований, которые оценивают качество жизни пациентов с различными коморбидными заболеваниями, растет ежегодно. Артериальная гипертензия и подагра не являются исключением. Существуют трудности в ведении данной категории больных на первичном
Кузьміна, Г.П.   +1 more
core  

The experiences and perspectives of people with gout on urate self‐monitoring

open access: yesHealth Expectations
Introduction Gout management remains suboptimal despite safe and effective urate‐lowering therapy. Self‐monitoring of urate may improve gout management, however, the acceptability of urate self‐monitoring by people with gout is unknown.
Toni J. F. Michael   +8 more
doaj   +1 more source

AB0867 DEPRESSIVE SYMPTOMS INFLUENCE SUCCESS OF ALLOPURINOL AS URATE LOWERING THERAPY [PDF]

open access: bronze, 2019
Sylvie Mrug   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy